Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p

Cisplatin has been used as the first-line chemotherapy to treat advanced nasopharyngeal carcinoma (NPC), while acquired cisplatin resistance resulting from epigenetic regulation is not well understood. The relative expression of LINC00346 was detected in healthy persons, cisplatin-sensitive (CS) pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Biol
Asıl Yazarlar: Cui, Zheqing, Pu, Tian, Zhang, Yujie, Wang, Jia, Zhao, Yulin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Royal Society 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276527/
https://ncbi.nlm.nih.gov/pubmed/32397872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsob.190286
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller